Zobrazeno 1 - 10
of 65
pro vyhledávání: '"C. Mitsouli"'
Autor:
Alice Maniatis, K. Papanastasiou, Anastasia Pouli, Konstantinos Zervas, C. Mitsouli, M. Chatziyianni, V. Perifanis
Publikováno v:
European Journal of Haematology. 57:142-148
Results of studies using IFN-alpha treatment for maintaining remission and prolonging survival in multiple myeloma (MM) are in conflict and trials seeking optimum use for this biological response modifier are continuing. Between 1989 and 1993 a prosp
Autor:
Konstantinos Zervas, Alice Maniatis, E. Terpos, C. Mitsouli, Meletios A. Dimopoulos, Souzana Delibasi, Marie-Christine Kyrtsonis, A. Anagnostopoulos, N. Anagnostopoulos, D Mihou, Eirini Katodritou, P Zikos, Anastasia Pouli
Publikováno v:
Annals of Oncology. 18:1369-1375
Background: We have previously demonstrated that vincristine, liposomal doxorubicin and dexamethasone (VAD-doxil) is equally effective with VAD-bolus yielding objective response rates of 61% as first-line treatment in multiple myeloma (MM). In a phas
Autor:
X, Papanikolaou, D, Maltezas, P, Repousis, A, Athanassopoulos, S, Alexia, K, Megalakaki, M, Kotsopoulou, C, Mitsouli-Mentzikof
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 13(2)
To study the toxicity of high dose chemotherapy (HDCT) in multiple myeloma (MM) patients and its impact on event free survival (EFS) and overall survival (OS), and also the impact of thalidomide maintenance therapy on EFS and OS after HDCT.From April
Autor:
M, Dadacaridou, X, Papanicolaou, D, Maltesas, C, Megalakaki, P, Patos, K, Panteli, P, Repousis, C, Mitsouli-Mentzikof
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 12(1)
The purpose of this study was to assess the efficacy and toxicity of DCEP (dexamethasone, cyclophosphamide, etoposide, cisplatin), as third-line regimen in relapsed or refractory multiple myeloma (MM) patients.Twelve patients (11 men, 1 woman, aged 3
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 11(2)
To present the clinical course and laboratory results of leukemic patients with candidemia and to comment on the incidence and clinical findings of mycoses in this particular patient population.From 2002 to 2005 in the Department of Hematology of our
Autor:
Elina Vervessou, Dimitra Gika, N. Anagnostopoulos, G. Kouvatseas, George Hamilos, Irini Xilouri, T. Economopoulos, A. Zomas, T. Karmiris, K. Matsis, Meletios A. Dimopoulos, K. Bourantas, Konstantinos Zervas, Paraskevi Roussou, Argiris Symeonidis, C. Mitsouli
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 14(8)
Backgroud: Waldenstrom’s macroglobulinemia (WM) is an unusual lymphoplasmacytoid lymphoma characterized by the presence of a serum monoclonal immunoglobulin M. Although several studies have evaluated possible prognostic factors of this disease, few
Purpose : Waldenstrom’s macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma in which CD20 is usually expressed on tumor cells. There is evidence that patients with WM may benefit from treatment with the anti-CD20 monoclonal antibody ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0518c385b602184f7263d06ce16f1a92
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3081807
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3081807
Autor:
Aikaterini Megalakaki, C. Mitsouli, V. Koumaki, J. Iakovidou, C. Pontikoglou, George D. Eliopoulos, Helen A. Papadaki
Publikováno v:
Annals of Hematology. 83:791-792